Video: 2020 European Drug Report: Key Issues


High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the (EMCDDA in its European Drug Report 2020: Trends and Developments. In its latest annual review — marking 25 years of monitoring — the agency describes the drug situation at the end of 2019, along with recent changes brought by the COVID-19 pandemic in early 2020.

This video presents the key issues of the report.

Related

Main subject
Keywords
Target audience
Type
  • Creative Commons Attribution 4.0 International (CC BY 4.0)

Related assets in the Media library

Prevalence of drug in Europe. Shows that cannabis is the most used drug, followed by cocaine. Heroin and other opioids account for approximately 75% of all drug-related fatalities.
At a glance — estimates of drug use in the European Union
Screenshot of the presentation of the European Drug Report 2023 by EMCDDA DIrector Alexis Goosdeel
European Drug Report 2023: Presentation by EMCDDA Director Alexis Goosdeel
Thumbnail of video speech by Franz Pietsch, Chair of the EMCDDA Management Board
European Drug Report 2023: Speech by Chair of EMCDDA Management Board Franz Pietsch
screen shot of Franz Pietsch before a European and Austrian flag making a speech
Launch of the 2022 European Drug Report: speech by Chair of EMCDDA Management Board Franz Pietsch
photo of Commissioner Ylva Johansson during her video speech for the launch of the 2022 European Drug Report
Launch of the 2022 European Drug Report: speech by Commissioner Ylva Johansson
Video screenshot of the press conference on occasion of the European Drug Report launch with Kathryn Robertson, Media relations, and EMCDDA Director Alexis Goosdeel seated in the launch studio.
Video: Launch of the 2021 European Drug Report: Online media event
Top